Triona N. Chonghaile
123 St. Stephen's Green
Paraguay
Paraguay
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Inhibition of HDAC6 alters fumarate hydratase activity and mitochondrial structure.
Journal: Nature communications
Published: October 16, 2024
First-in-class metallo-PROTAC as an effective degrader of select Pt-binding proteins.
Journal: Chemical communications (Cambridge, England)
Published: October 04, 2023
Identification of a mechanism-based binding mode for a histone deacetylase 6 inhibitor.
Journal: Nature communications
Published: September 26, 2023
Steroid-free combination of 5-azacytidine and venetoclax for the treatment of multiple myeloma.
Journal: Haematologica
Published: June 29, 2023
Histone Deacetylase 6 Inhibition Exploits Selective Metabolic Vulnerabilities in LKB1 Mutant, KRAS Driven NSCLC.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: August 16, 2022
Editorial: Cell Death and Targeted Cancer Therapies.
Journal: Frontiers in cell and developmental biology
Published: June 13, 2022
Advances in the Design and Development of PROTAC-mediated HDAC Degradation.
Journal: Current topics in medicinal chemistry
Published: July 01, 2021
Shining a light on metabolic vulnerabilities in non-small cell lung cancer.
Journal: Biochimica et biophysica acta. Reviews on cancer
Published: June 04, 2020
JAK3 mutations and mitochondrial apoptosis resistance in T-cell acute lymphoblastic leukemia.
Journal: Leukemia
Published: September 09, 2019
PRC2 loss induces chemoresistance by repressing apoptosis in T cell acute lymphoblastic leukemia.
Journal: The Journal of experimental medicine
Published: March 22, 2018
BCL-2 modulates the unfolded protein response by enhancing splicing of X-box binding protein-1.
Journal: Biochemical and biophysical research communications
Published: August 20, 2015
Last Updated: 09/26/2026